-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
- Inhibikase Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 7.54M shares, a 44.2% increase year-over-year.
- Inhibikase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.33M shares, a 26.3% increase from 2022.
- Inhibikase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.22M shares, a 76.8% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)